US PrEP care cascade analysis suggests that major, structural barriers need to be addressed for PrEP to have an impact
Indiana HIV outbreak offers lessons about containing local outbreaks and need for harm reduction
NHS urgently needs to make PrEP available, say HIV prevention organisations
European CDC cautious about PrEP
New US guidelines recommend PrEP
Who will PrEP be for?
Biomedical HIV prevention – the social complexities of achieving effectiveness
PrEP probably cost effective in middle-income countries, but too costly to slash HIV incidence
Changing the way HIV prevention is delivered – a roadmap
